Related Experiment Video
Updated: Jun 25, 2026
04:11
Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
[Evaluation of hepatitis B virus genotyping EIA kit].
Yasuhito Tanaka1, Fuminaka Sugauchi, Kentaro Matsuuraa
1Department of Clinical Molecular Informative Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan. ytanaka@med.nagoya-cu.ac.jp
Rinsho Byori. the Japanese Journal of Clinical Pathology
|February 21, 2009
Summary
This study validates an enzyme immunoassay (EIA) for Hepatitis B virus (HBV) genotyping. The EIA accurately identifies HBV genotypes A, B, C, and D, proving reliable for clinical use.
Area of Science:
- Virology
- Immunology
- Molecular Diagnostics
Context:
- Hepatitis B virus (HBV) genotyping is crucial for clinical management.
- Accurate and reproducible HBV genotyping methods are needed.
Purpose:
- To evaluate the reproducibility, accuracy, and sensitivity of an enzyme immunoassay (EIA) for HBV genotyping.
- To assess the performance of an EIA detecting genotype-specific epitopes in the PreS2 region for HBV genotypes A, B, C, and D.
Summary:
- The EIA demonstrated excellent inter- and intra-assay reproducibility and stability under various storage conditions.
- Concordance with DNA sequencing was high (95.6%), with discrepancies attributed to low HBsAg titers or mutations.
- The EIA successfully genotyped samples even when HBV DNA was negative, showing high sensitivity.
Impact:
- This EIA offers a reliable, sensitive, and user-friendly method for HBV genotyping.
- The assay's utility in clinical settings can aid in patient management and epidemiological studies.
- The findings support the adoption of this EIA for routine clinical diagnostics.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:33Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.